Clinical Trials
The internationally awarded clinical excellence, with certifications and accreditations in every specialty, along with extensive geographical spread, makes Affidea Group the preferred healthcare provider for leading pharmaceutical companies and medical institutions, as well as AI program developers and medical device manufacturers, both in Greece and abroad. In Greece, the Clinical Studies Department has been active since 2014 and currently manages dozens of active clinical studies. The areas in which it contributes with its clinical research include, among others, Alzheimer's disease, melanoma, Non-Hodgkin lymphoma, multiple myeloma, lymphoma, multiple sclerosis, spondyloarthritis, and cancers of the breast, prostate, lungs, and colon. At Affidea, we are fully committed to improving clinical outcomes for the benefit of patients. We offer our technological equipment, clinical excellence, and renowned physicians to assist researchers in developing more personalized pharmaceutical formulations. We collaborate with our accredited medical centers to participate in clinical trials, with the aim of saving more lives in the future.
The internationally awarded clinical excellence, with certifications and accreditations in every specialty, along with extensive geographical spread, makes Affidea Group the preferred healthcare provider for leading pharmaceutical companies and medical institutions, as well as AI program developers and medical device manufacturers, both in Greece and abroad.
With over 20 years of experience collaborating with the pharmaceutical industry, Affidea participates in more than 400 innovative pharmaceutical clinical trials across 10 different European countries where it operates.
In Greece, the Clinical Trials Department has been active since 2014 and currently manages dozens of active clinical studies. The areas in which Affidea contributes with its clinical research include, but are not limited to, Alzheimer's disease, melanoma, Non-Hodgkin's lymphoma, multiple myeloma, lymphoma, multiple sclerosis, spondyloarthritis, and cancers of the breast, prostate, lungs, and colon.
At Affidea, we are fully committed to improving clinical outcomes for the benefit of patients. We offer our technological equipment, clinical excellence, and esteemed physicians to assist researchers in developing more personalized pharmaceutical formulations and collaborate with our accredited medical centers to participate in clinical trials, aiming to save more lives in the future.
